Traws Net Debt To E B I T D A from 2010 to 2024
| TRAW Stock | 5.02 0.31 5.82% |
Net Debt To EBITDA | First Reported 2010-12-31 | Previous Quarter 1.02657529 | Current Value 1.01 | Quarterly Volatility 1.09892704 |
Check Traws Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Traws Pharma's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Depreciation And Amortization of 15.6 K or Total Revenue of 193.2 K, as well as many indicators such as Price To Sales Ratio of 1.1 K, Dividend Yield of 0.0 or PTB Ratio of 30.16. Traws financial statements analysis is a perfect complement when working with Traws Pharma Valuation or Volatility modules.
Traws | Net Debt To E B I T D A |
Latest Traws Pharma's Net Debt To E B I T D A Growth Pattern
Below is the plot of the Net Debt To E B I T D A of Traws Pharma over the last few years. It is a leverage ratio that indicates a company's ability to pay off its incurred debt. It compares a company's net debt (total debt minus cash) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). Traws Pharma's Net Debt To EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Traws Pharma's overall financial position and show how it may be relating to other accounts over time.
| Net Debt To E B I T D A | 10 Years Trend |
|
Net Debt To E B I T D A |
| Timeline |
Traws Net Debt To E B I T D A Regression Statistics
| Arithmetic Mean | 1.17 | |
| Geometric Mean | 0.75 | |
| Coefficient Of Variation | 93.95 | |
| Mean Deviation | 0.76 | |
| Median | 0.91 | |
| Standard Deviation | 1.10 | |
| Sample Variance | 1.21 | |
| Range | 3.7805 | |
| R-Value | 0.18 | |
| Mean Square Error | 1.26 | |
| R-Squared | 0.03 | |
| Significance | 0.52 | |
| Slope | 0.04 | |
| Total Sum of Squares | 16.91 |
Traws Net Debt To E B I T D A History
About Traws Pharma Financial Statements
Traws Pharma investors use historical fundamental indicators, such as Traws Pharma's Net Debt To E B I T D A, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Traws Pharma. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Debt To EBITDA | 1.03 | 1.01 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Traws Stock Analysis
When running Traws Pharma's price analysis, check to measure Traws Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Traws Pharma is operating at the current time. Most of Traws Pharma's value examination focuses on studying past and present price action to predict the probability of Traws Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Traws Pharma's price. Additionally, you may evaluate how the addition of Traws Pharma to your portfolios can decrease your overall portfolio volatility.